Extract Or Material Containing Or Obtained From An Alga As Active Ingredient (e.g., Chlorella, Seaweed, Laver, Kelp, Etc.) Patents (Class 424/195.17)
  • Patent number: 10300012
    Abstract: The invention relates to a topical veterinary composition for animals. It is characterized in that it comprises, in a physiologically acceptable medium, extracts of boldo Peumus boldus and extracts of meadowsweet Spiraea ulmaria. The invention applies in particular to preventing or treating or to assisting with the control of microbial infections.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: May 28, 2019
    Assignee: VIRBAC
    Inventor: Hugues Gatto
  • Patent number: 10286021
    Abstract: The present invention relates to a composition for the prevention or treatment of arthritis, the composition containing a Sargassum serratifolium extract as an active ingredient. The extract of Sargassum serratifolium according to the present invention has an excellent activity to reduce or inhibit the activity of IL-1?, IL-6, or TNF-?, which is an inflammatory cytokine, and has an excellent effect alleviating arthritis in an arthritis animal model so that it can be usefully used as a composition for treating arthritis. In addition, there is no cytotoxicity, and toxicity to the drug and side effects are avoided so that it can be safely used even for long-term use, and it is stable in the body.
    Type: Grant
    Filed: February 11, 2016
    Date of Patent: May 14, 2019
    Assignee: Pukyong National University Industry-University Cooperation Foundation
    Inventors: Hyeung-Rak Kim, Mi-Sung Kwon, Eun-Ji Joung
  • Patent number: 10279001
    Abstract: The present disclosure relates to compositions and related methods to reduce body weight, body fat, waist and hip size, plasma total cholesterol, LDL, triglycerides, blood glucose, leptin and C-reactive protein levels and increase in HDL and serotonin levels in an mammal. The LeptiCore® formulation disclosed, at both the low and high dosages, is helpful in the management of fat gain and its related complications. The higher dosage resulted in significantly greater reductions in body weight and triglyceride, blood glucose, and C-reactive protein levels, as well as increased serotonin levels.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: May 7, 2019
    Inventor: Julius Enyoug Oben
  • Patent number: 10279002
    Abstract: The present disclosure relates to compositions and related methods to reduce body weight, body fat, waist and hip size, plasma total cholesterol, LDL, triglycerides, blood glucose, leptin and C-reactive protein levels and increase in HDL and serotonin levels in an mammal. The LeptiCore® formulation disclosed, at both the low and high dosages, is helpful in the management of fat gain and its related complications. The higher dosage resulted in significantly greater reductions in body weight and triglyceride, blood glucose, and C-reactive protein levels, as well as increased serotonin levels.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: May 7, 2019
    Inventor: Julius Enyoug Oben
  • Patent number: 10232028
    Abstract: The present invention discloses isolates and fractions from a phyto-percolate and methods for affecting various cytokines by administering an effective amount of one or more of said isolates or fractions to an animal. In various exemplary embodiments, the isolates are useful for the treatment of bovine, canine and swine infection or inflammation, including bovine mastitis, by regulation of TNF-a, lactoferrin, IFN-?, IL-I ?, serum amyloid-A (SAA), IL-6 and/or ?-defensin associated with infection or an immune response generally.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: March 19, 2019
    Assignee: ZIVO BIOSCIENCE, INC.
    Inventor: Andrew Dahl
  • Patent number: 10226501
    Abstract: A method for treating a cancer in a mammal using an extract of a Phoenix dactylifera (i.e. date) fruit flesh is described, along with an extraction method. The extract may be formed into a dried powder and reconstituted into a variety of media for oral administration, intravenous administration, or other routes. The extract may also be administered to prevent the occurrence of cancer or to treat other ailments.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: March 12, 2019
    Assignee: King Abdulaziz University
    Inventors: Taha Abdullah Kumosani, Elie Kamil Barbour, Fazal Khan, Kalamegam Gauthaman, Adel Abuzenadah
  • Patent number: 10137068
    Abstract: A method for the color retention of dyed keratin fibers is provided herein. The method includes i. applying a cosmetic composition to dyed keratin fibers as a pretreatment agent for keratin. The method further includes ii. subjecting the keratin fibers to a dyeing and/or brightening within a period of about 5 seconds to about 24 hours after to step i. The cosmetic composition has, based on its own weight, from about 0.01 to about 4.00% by weight of at least one alum and a pH value in the range of about 2.5 to about 5.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: November 27, 2018
    Assignee: Henkel AG & Co. KGaA
    Inventors: Erik Schulze zur Wiesche, René Krohn
  • Patent number: 10111912
    Abstract: The present invention relates to a formulation comprising Propolis, Ginseng root and Zingiber officinale extracts to be used in the treatment, prevention of various respiratory diseases or alleviation and/or elimination of symptoms thereof and a method for preparing said formulation.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: October 30, 2018
    Assignee: MONTERO GIDA SANAYI VE TICARET A.S.
    Inventors: Ümit Cifter, Nazife Arabacioglu, Özlem Toker
  • Patent number: 10022412
    Abstract: The present invention provides a composition for preventing, improving or treating periodontal diseases comprising extract of mangosteen. The composition of the present invention has excellent anti-bacterial and anti-inflammatory effects against bacteria inducing periodontal diseases as comprising extract of mangosteen, or alpha-mangosteen or gamma-mangosteen derived from thereof, and thereby it can be widely used for medicines and foods for preventing, improving or treating periodontal diseases.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: July 17, 2018
    Assignee: MEDI BIO LAB. CO., LTD.
    Inventors: Dae Sung Lee, Yoon Seok Ko, Chan Ho Kim, Min Jung Ryu, Young Jin Kim, Ik Jin In, Sung Kwon Lee
  • Patent number: 10010569
    Abstract: The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.
    Type: Grant
    Filed: November 6, 2013
    Date of Patent: July 3, 2018
    Assignees: University of Florida Research Foundation, Incorporated, Smithsonian Institution
    Inventors: Hendrik Luesch, Valerie J. Paul, Rui Wang
  • Patent number: 10005823
    Abstract: The present invention provides 11 peptides represented as SEQ ID NO: 1-11. The peptides have the ability of anti-virus and bacteria, and can reduce infections, clean necrotic tissue, and promote debridement so as to facilitate wound healing. Moreover, the peptides can also induce collagen secretion and activate fibroblasts and keratinocytes so as to stimulate angiogenesis. Thus, the peptides of the present invention are suitable for development as a health caring product to help an individual enhance recovery and immunity.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: June 26, 2018
    Assignee: TCI CO., LTD
    Inventors: Yung-Hsiang Lin, Chin-Hsiu Yu, Yun-Ching Tsai, Ciao-Ting Chen, Hsiang-Ling Su
  • Patent number: 9968632
    Abstract: The instant invention provides a method and composition for treating or preventing osteoarthritis, joint effusion, joint inflammation and pain, synovitis, lameness, post operative arthroscopic surgery, deterioration of proper joint function including joint mobility, the reduction or inhibition of metabolic activity of chondrocytes, the activity of enzymes that degrade cartilage, said method comprising administering effective amounts of Boswellia Serrata, effective amounts of freeze dried green lipped mussle, effective amounts of white willow bark extract containing salicin, effective amounts of angelica root, effective amounts of glucosamine and salts thereof, effective amounts of chondroitin and salts thereof and effective amounts of omega 3 fatty acids.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: May 15, 2018
    Assignee: Natures Products, Inc.
    Inventors: James Sullivan, Forrest Haag, Lianne Maso de Moya
  • Patent number: 9949943
    Abstract: A method for treating neurodegenerative diseases including the step of administering an isothiocyanate functional surfactant to an area affected by a neurodegenerative disease, wherein the isothiocyanate functional surfactant comprises at least one isothiocyanate functional group associated with an aliphatic and/or aromatic carbon atom of the isothiocyanate functional surfactant.
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: April 24, 2018
    Assignee: THE WILLIAM M. YARBROUGH FOUNDATION
    Inventor: Michael E. Silver
  • Patent number: 9901098
    Abstract: The present invention relates to a method for treating plant pests or pathogens. The disclosed method of protecting plants against pests includes a plant protection composition, wherein the plant protection composition comprises a water-soluble activator and a benefit active precursor. The composition is applied externally to the plant where a benefit active species is generated in situ, thus mitigating the pest.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: February 27, 2018
    Assignee: TDA Research, Inc.
    Inventors: William Bell, Christopher Brian France
  • Patent number: 9877916
    Abstract: A composition comprising an extract from damaged plant parts from the Moringaceae genus, at least one oligopeptide, at least one extract from the Laminaria genus, and whey protein and a method for stimulating collagen synthesis in skin cells.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: January 30, 2018
    Assignee: ELC Management LLC
    Inventors: Nadine Pernodet, Krystle Corallo, Dawn Layman, Donald Collins
  • Patent number: 9839709
    Abstract: Provided herein is a method of reducing a microbial infection of a heparinized surface wherein heparin precipitation is reduced as compared to a control. In some embodiments a composition comprising ethanol and isopropanol is applied to the surface. In other embodiments, two or more ethanol compositions are applied and removed sequentially from the surface prior to contacting the surface with a biological fluid, tissue or vessel, wherein the composition in each successive administration comprises an increased amount of ethanol. Also provided is a method of reducing a microbial infection of a surface comprising applying a mucilage extract from an Opuntia ficus indica species to the surface.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: December 12, 2017
    Assignee: University of South Florida
    Inventors: Mark Lawrence Kayton, Norma Alcantar, Daniel Restrepo, Nicholas S. Laconi, Audrey Lynn Buttice, Michael Pierce Ebaugh
  • Patent number: 9820497
    Abstract: There is provided pet food comprising astaxanthin and/or an ester thereof as an active component and having an effect of deodorizing excrement such as urine and feces, effects of improving sleep, sensibility such as perception and cognition, and visual sense, and an effect of treating, improving or preventing diabetes and diabetic complications. The pet food can deodorize excrement such as urine and feces, improve sleep, sensibility such as perception and cognition, and visual sense, and treat, improve or prevent diabetes and diabetic complications.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: November 21, 2017
    Assignee: FUJI CHEMICAL INDUSTRY CO., LTD.
    Inventors: Tomoaki Honda, Jiro Takahashi
  • Patent number: 9782413
    Abstract: The present invention relates to a novel pharmaceutical composition free of gastric coating comprising anagrelide hydrochloride in combination with a non-pH dependent polymer and a pharmaceutically acceptable water soluble acid and its use for the treatment of essential thrombocythemia.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: October 10, 2017
    Assignee: AOP ORPHAN PHARMACEUTICALS AC
    Inventors: Rudolf Widmann, Georg Strieder
  • Patent number: 9758644
    Abstract: Described is the use of soluble indigestible fiber for inducing lysis of the cell walls of eukaryotic microalgae in the lumen of the intestine of an omnivorous or carnivorous animal including an intestinal flora and also for synergistically increasing the effect of the indigestible fiber in the induction of the growth of the intestinal flora of an omnivorous or carnivorous animal. The subject matter of the invention is also the composition intended for this use and for a method of improving the health or of food supplementation.
    Type: Grant
    Filed: July 20, 2009
    Date of Patent: September 12, 2017
    Assignee: ROQUETTE FRERES
    Inventors: Laetitia Deremaux, Daniel Wils
  • Patent number: 9687439
    Abstract: A composition comprising an extract from damaged plant parts from the Moringaceae genus, at least one oligopeptide, at least one extract from the Laminaria genus, and whey protein and a method for stimulating collagen synthesis in skin cells.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: June 27, 2017
    Assignee: ELC Management LLC
    Inventors: Nadine Pernodet, Krystle Corallo, Dawn Layman, Donald Collins
  • Patent number: 9688595
    Abstract: A scalable and sustainable process for production of renewable chemicals and biofuel from seaweed in its own juices or in seawater without desalination of the seaweeds is provided herein. The process as disclosed in the preset invention is an eco-friendly process for production of renewable chemicals and biofuel with an easy method of disposing of the waste streams. Further, the process as disclosed in the present invention is cost effective, suitable since transporting and storing the raw material obtained in the form of slurry of the seaweeds because of its lesser bulk is easy, easier handling due to its free flowing nature and its direct use for further processing to obtain renewable chemicals and/or biofuel.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: June 27, 2017
    Assignee: Sea6 Energy Private Ltd.
    Inventors: Shrikumar Suryanarayan, Sri Sailaja Nori, Sawan Kumar, Nelson Vadassery, Sowmyalakshmi Balendiran, Sayash Kumar
  • Patent number: 9642789
    Abstract: The present invention provides methods of treating baldness in a subject and generating new hair follicles, comprising epidermal disruption and administration of a compound that promotes a differentiation of an uncommitted epidermal cell into a hair follicle cell. The present invention also provides methods for hair removal and inducing hair pigmentation.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: May 9, 2017
    Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: George Cotsarelis, Mayumi Ito
  • Patent number: 9642887
    Abstract: Compositions and methods for the prevention and treatment of blepharitis, where the compositions include verbascoside, oligopeptide-10, and sulfonated shale oil, and the preparation of such compositions.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: May 9, 2017
    Inventors: Shetal Amit Shah, Amit Rajendra Shah
  • Patent number: 9603881
    Abstract: The present invention relates to bioactive fractions isolated from stress-induced photosynthetic organisms. The present invention also relates to methods of producing stress-induced photosynthetic organisms suitable for isolating altered bioactive fractions. The present invention further relates to bioactive compositions, bioactive topical formulations, and methods of their use.
    Type: Grant
    Filed: November 12, 2010
    Date of Patent: March 28, 2017
    Assignee: ISP INVESTMENTS LLC
    Inventors: Michael Koganov, Olga Dueva-Koganov, Paul Recht, Artyom Duev
  • Patent number: 9597280
    Abstract: The invention provides cosmetic compositions comprising microalgal biomass, whole microalgal cells, and/or microalgal oil in combination with one or more other cosmetic ingredients, and methods of making such compositions. In preferred embodiments, the microalgal components of the cosmetic compositions are derived from microalgal cultures grown heterotrophically and which comprise at least 10% oil by dry weight.
    Type: Grant
    Filed: May 13, 2014
    Date of Patent: March 21, 2017
    Assignee: TerraVia Holdings, Inc.
    Inventor: Tammy Yaiser
  • Patent number: 9566262
    Abstract: The present invention provides a method of suppressing mast cell differentiation and/or itch in the skin of a subject, comprising topically administering to the skin in need thereof an effective amount of fucoxanthin or a derivative thereof.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: February 14, 2017
    Assignees: The Ritsumeikan Trust, Logic Co., Ltd.
    Inventor: Takashi Fujita
  • Patent number: 9567557
    Abstract: The invention relates to the field of microalgae culture and specifically relates to a trap-type carbon supplement device and carbon supplement method for cultivating microalgae in an open pond. The trap-type carbon supplement device for cultivating microalgae in an open pond, comprises a trap-type container, a partition plate and a gas distributor, wherein the gas distributor is positioned at the culture solution inlet of the trap-type carbon supplement device; the thickness of the trap-type carbon supplement device on the side of the culture solution inlet is 0.5-2 times of the depth of the culture solution in the open pond; the gap between the lower end of the partition plate and the bottom of the trap-type container is 0.5-2 times of the thickness of the trap-type carbon supplement device on the side of the culture solution inlet; the upper end of the partition plate is higher than the wall of the trap-type container; and the width of the partition plate is matched with the trap-type container.
    Type: Grant
    Filed: May 7, 2012
    Date of Patent: February 14, 2017
    Assignee: Institute of Process Engineering, Chinese Academy of Sciences
    Inventors: Wei Cong, Zhongliang Sun, Ming Liu, Xia Wu, Dongmei Zhang, Shumei Wen
  • Patent number: 9517214
    Abstract: The invention is in particular concerned with a food product comprising one or more fats or oils and a carotenoid compound. The products of the invention may be used in reducing elevated total cholesterol, triglycerides and inflammatory damage, as well as improving tissue microcirculation and tissue oxygenation.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: December 13, 2016
    Assignee: IP Science Limited
    Inventor: Ivan Petyaev
  • Patent number: 9463176
    Abstract: It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises a) a lipid fraction comprising at least one of docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); b) a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine and/or taurine; and c) a mineral fraction comprising at least one of manganese and molybdenum, the health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: October 11, 2016
    Assignee: N.V. Nutricia
    Inventor: Robert J. J. Hageman
  • Patent number: 9345258
    Abstract: The present invention provides a synergistic phytochemical composition from Curcuma longa possessing analgesic and anti inflammatory activity used for management of chronic pain and treatment of osteoarthritis. The composition comprises Curcuma longa oil and Curcuma longa water extract. The relative amounts of these materials may be 0.5-5% by weight and 95-99.5% by weight respectively; and optionally pharmaceutically acceptable excipients. The present invention also provides a process for preparing the composition.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: May 24, 2016
    Assignee: Natural Remedies PVT Ltd.
    Inventor: Amit Agarwal
  • Patent number: 9220740
    Abstract: Estrogenic extracts of Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family are provided. Also provided are methods of using said extracts to achieve an estrogenic effect, especially in a human, e.g. a female human. In some embodiments, the methods include treatment of climacteric symptoms. In some embodiments, the methods include treatment of estrogen receptor positive cancer, such as estrogen responsive breast cancer. In some embodiments, the methods include treatment or prevention of osteoporosis.
    Type: Grant
    Filed: January 13, 2010
    Date of Patent: December 29, 2015
    Assignee: BIONOVO, INC.
    Inventor: Isaac Cohen
  • Patent number: 9161564
    Abstract: New dietary supplement composition comprising, as active ingredients: NADH and/or NAD+ Coenzyme Q10 Vitamin C (Ascorbic Acid) Serine and/or Phosphoserine to be used for stimulating/improving/increasing the production of naturally occurring adrenaline, thus reducing sleepiness caused by particular drugs intake. The dietary supplement according to the present invention is particularly advantageous for professional drivers and persons who usually take drugs having sleepiness as major side effect.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: October 20, 2015
    Assignee: VITAE NATURAL NUTRITION, S.L.
    Inventors: Josep Maria Suñé Negre, Raimon Cortada Pasola, Manuel Roig Carreras, Rocio Sarrate Arjona
  • Patent number: 9145534
    Abstract: A composition comprises a fat phase wherein the fat phase comprises: more than 10 wt. % DHA and/or EPA or derivatives thereof; or more than 5 wt. % GLA or a derivative thereof; or more than 10 wt. % of GLA, EPA and/or DHA in total or derivatives thereof; and secoisolariciresinol (SECO) or a derivative thereof, with the proviso that when the composition comprises GLA, the composition is substantially free of isoflavones. The composition and mixtures or blends comprising the composition may be used for the treatment of PMS and prostate conditions.
    Type: Grant
    Filed: July 27, 2007
    Date of Patent: September 29, 2015
    Assignee: Bioriginal Food & Science Corporation
    Inventors: Rakesh Kapoor, Jeanette M Fusick
  • Patent number: 9040056
    Abstract: Compositions comprising a moisturizing agent, a desquamating agent, a mattifying agent and an agent that increases skin luminosity are disclosed herein. The compositions are useful for moisturizing, desquamating, mattifying, and increasing the luminosity in skin of an individual having a Fitzpatrick Skin Type IV, V, or VI. Also disclosed are methods for moisturizing, desquamating, mattifying, and increasing the luminosity in skin, comprising administering to an individual having a Fitzpatrick Skin Type IV, V, or VI, the present compositions.
    Type: Grant
    Filed: July 2, 2012
    Date of Patent: May 26, 2015
    Assignee: ELC Management LLC
    Inventors: Lieve Declercq, Muriel Ghersin, Louis De Saint Michel, Joseph Scott Grigsby
  • Publication number: 20150140030
    Abstract: The invention relates to a method for preparing a composition that is very rich in squalene produced by fermentation of micro-organisms. The method is characterised in that it comprises a purification step selected from the group including: supercritical CO2 extraction in a multi-stage counter-current fractionation column with extract reflux, and short-path molecular distillation.
    Type: Application
    Filed: April 15, 2013
    Publication date: May 21, 2015
    Inventors: Philippe Looten, Samuel Patinier, Michel Perrut, Vincent Perrut
  • Publication number: 20150140031
    Abstract: Systems and methods of weight management and compositions or formulations useful therein are disclosed and described.
    Type: Application
    Filed: September 3, 2014
    Publication date: May 21, 2015
    Inventors: Steven M. Wood, Stephen J. Poole, Doug Burke, Mark Bartlett, Angela Mastaloudis
  • Patent number: 9034342
    Abstract: The present disclosure relates to compositions and related methods to reduce body weight, body fat, waist and hip size, plasma total cholesterol, LDL, triglycerides, blood glucose, leptin and C-reactive protein levels and increase in HDL and serotonin levels in an mammal. The LeptiCore® formulation disclosed, at both the low and high dosages, is helpful in the management of fat gain and its related complications. The higher dosage resulted in significantly greater reductions in body weight and triglyceride, blood glucose, and C-reactive protein levels, as well as increased serotonin levels.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: May 19, 2015
    Assignee: Gateway Health Alliances, Inc
    Inventor: Julius E. Oben
  • Publication number: 20150132338
    Abstract: A composition for food and a fat absorption inhibitor, each including a seaweed polyphenol and a tea extract.
    Type: Application
    Filed: January 21, 2015
    Publication date: May 14, 2015
    Applicant: FUJIFILM Corporation
    Inventors: Yuriko ODA, Fumitaka UEDA
  • Publication number: 20150125923
    Abstract: The present invention generally relates to compositions and methods of delivering substances in a dry mode, wherein the compositions include a surface layer disposed on the outer surface of the composition that is permeable to carbon dioxide and oxygen. The compositions may be used to deliver microorganisms to remove contaminates, such as oil, chemical, waste, or sewage, from soil, water, or air. In other embodiments, the compositions can also be used for delivering liquid food, liquid food additives, liquid biotech agricultural ingredients, conventional liquid agricultural ingredients, liquid human wellness and dietary supplements, and liquid fragrances and beauty products.
    Type: Application
    Filed: October 5, 2011
    Publication date: May 7, 2015
    Applicant: DryLet LLC
    Inventors: Ramiro Trevino, Steven R. Ellis
  • Publication number: 20150110758
    Abstract: A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.
    Type: Application
    Filed: January 5, 2015
    Publication date: April 23, 2015
    Inventor: Omar M. Amin
  • Publication number: 20150098963
    Abstract: A method for stimulating collagen synthesis in aging skin cells in need of treatment by topically applying a composition comprising at least one extract from Laminaria genus, at least one extract from the Narcissus genus, and at least one peptide that stimulates SIRT6 activity in the form of a peptide or a yeast extract where the peptide is component of the extract; and a treatment composition comprising at least one extract from Laminaria genus, at least one extract from the Narcissus genus; and at least one peptide that stimulates SIRT6 activity.
    Type: Application
    Filed: October 3, 2013
    Publication date: April 9, 2015
    Inventors: Nadine A. Pernodet, Donald F. Collins
  • Patent number: 8986667
    Abstract: The present invention relates to a mixture, having a skin-tightening effect, which is made up of: 10 to 80% by weight of a polysaccharide, preferably of an alginate, having a molecular weight of less than 600,000 Daltons, preferably less than 400,000 Daltons and more preferably less than 200,000 Daltons, 15 to 75% by weight of a polyhydroxylated agent selected from sugars and their derivatives, particularly sugar esters and sugar, ethers, preferably sorbitol, 3 to 15% by weight of poly(vinyl alcohol) or polyvinylpyrrolidone, and 0 to 25% by weight of cellulose or of a derivative of cellulose, such as carboxymethylcellulose or hydroxymethylcellulose. The present invention also relates to cosmetic compositions which contain this mixture. These cosmetic compositions enable a mechanical smoothing of the surface of the skin to be obtained progressively with great comfort of use and enables a good fixing of make-up products.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: March 24, 2015
    Assignee: LVMH Recherche
    Inventors: Hervé Delage-Grouiller, Brigitte Noe, Christian Mahe
  • Patent number: 8974796
    Abstract: The present invention provides a side effect inhibitor of drug therapy for colorectal cancer using 5-fluorouracil, comprising fucoidan or a fucoidan-containing material; a method for inhibiting side effects of drug therapy for colorectal cancer using 5-fluorouracil, which comprises administering fucoidan or a fucoidan-containing material to a colorectal cancer patient; and use of fucoidan or a fucoidan-containing material for the production of a side effect inhibitor of drug therapy for colorectal cancer using 5-fluorouracil.
    Type: Grant
    Filed: February 22, 2010
    Date of Patent: March 10, 2015
    Assignees: National University Corporation Tottori University, Marine Products Kimuraya Co., Ltd.
    Inventors: Masahide Ikeguchi, Manabu Yamamoto, Takayuki Kimura, Yasunari Miki
  • Publication number: 20150064213
    Abstract: A topical composition includes an amount of a concentrate derived from Ecklonia maxima (sea bamboo) effective for treating the skin, hair and/or nails and a dermatologically acceptable carrier.
    Type: Application
    Filed: August 27, 2014
    Publication date: March 5, 2015
    Inventor: Camilla Taft
  • Patent number: 8961993
    Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.
    Type: Grant
    Filed: July 18, 2013
    Date of Patent: February 24, 2015
    Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
  • Publication number: 20150050316
    Abstract: Disclosed is a cosmetic or dermatological preparation which comprises one or more extracts of Saxifraga oppositifolia (purple saxifrage) and/or one or more extracts of Soldanella alpina (alpine snowbell). The use of these extracts to combat extrinsic and intrinsic skin aging is likewise described.
    Type: Application
    Filed: August 7, 2014
    Publication date: February 19, 2015
    Inventors: Daniel STANGL, Bernhard DUDLER
  • Publication number: 20150050259
    Abstract: The present invention relates to a nutraceutical formulation useful for increasing the concentrations of circulating stem cells in a mammal. Disclosed are compositions of matter for increasing the concentrations of circulating stem cells in the blood, consisting of a mixture of natural compounds comprising: ashwagandha, milk thistle, vitamin D3, fucoidan, and garcinia indica. One embodiment of the present invention describes a method for increasing circulating concentrations of stem cells in a mammal using an oral delivery vehicle containing said combination of natural compounds.
    Type: Application
    Filed: April 30, 2014
    Publication date: February 19, 2015
    Inventor: Amit Patel
  • Patent number: 8940340
    Abstract: Systems and methods for maintaining the dominance of Nannochloropsis in an algae cultivation system are provided. Exemplary methods include applying an effective amount of a disinfectant to Nannochloropsis growing in an algae cultivation system. Another method for maintaining the dominance of Nannochloropsis in an algae cultivation system includes adjusting a salinity in the algae cultivation system to between approximately 0.5 PPT and 28 PPT. In a further method, the temperature of the algae cultivation system may be adjusted to between approximately 21 and 32 degrees Celsius (“° C.”). According to yet another method for maintaining the dominance of Nannochloropsis in an algae cultivation system, a salinity in the algae cultivation system may be adjusted to below that of seawater for a first predetermined period of time, and then the salinity in the algae cultivation system may be adjusted to a higher salinity for a second predetermined period of time.
    Type: Grant
    Filed: January 22, 2009
    Date of Patent: January 27, 2015
    Assignee: Aurora Algae, Inc.
    Inventors: Joseph Weissman, Guido Radaelli
  • Patent number: 8926984
    Abstract: In an embodiment of the invention, aqueous growth medium in a pond can be used to grow algae which can be pumped to a primary dewatering device where the algae can be separated from the harvested growth media based on the flow of the harvested growth media and gravity. The flow through the primary de-watering device can be optimized to maintain log phase growth in the pond, while minimizing the pumping cost and maximizing the concentration of total solids in the primary de-watered algae.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: January 6, 2015
    Assignee: Independence Bio-Products, Inc.
    Inventors: Christopher J. Davies, John Russell Teague, Ronald A. Erd
  • Patent number: RE45483
    Abstract: The present invention relates to a method for preventing obesity later in life by administering a certain nutritional composition to an infant with the age between 0 and 36 months. The composition comprises linoleic and alpha-linolenic acid.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: April 21, 2015
    Assignee: N.V. Nutricia
    Inventors: Renate Maria Louise Zwijsen, Gelske Speelmans, Eline Marleen Van Der Beek, Gunther Boehm